標題: Titlebook: Gene Therapy for Autoimmune and Inflammatory Diseases; Yuti Chernajovsky,Paul D. Robbins Book 2010 Birkh?user Basel 2010 Arthritis.Autoimm [打印本頁] 作者: 精明 時間: 2025-3-21 19:16
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases影響因子(影響力)
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases影響因子(影響力)學科排名
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases網(wǎng)絡公開度
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases網(wǎng)絡公開度學科排名
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases被引頻次
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases被引頻次學科排名
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases年度引用
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases年度引用學科排名
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases讀者反饋
書目名稱Gene Therapy for Autoimmune and Inflammatory Diseases讀者反饋學科排名
作者: hankering 時間: 2025-3-22 00:12
Perspectives for the future developments of gene therapy for autoimmune and inflammatory therapy,ally, therapeutic targeting and exploitation of microRNAs. Application of this broad knowledge is being facilitated by the improvement of gene delivery vectors whose characteristics are being constantly improved and transformed to achieve tissue targeting, long-term expression, transcriptional control and low immunogenicity.作者: 使激動 時間: 2025-3-22 01:05 作者: 外貌 時間: 2025-3-22 07:39
https://doi.org/10.1007/978-3-211-69325-4s animal model, experimental autoimmune encephalomyelitis (EAE). Since progressive forms of MS remain orphan of efficient therapies, the field is open for less conventional interventions such as gene therapy.作者: 可憎 時間: 2025-3-22 12:38
Introduction: Different Views of Psychologysues of arthritic joints, thereby redirecting their biology for sustained, local synthesis of therapeutic transgene products. A wide variety of transgenes and methods of delivery are currently under investigation for their capacity to block ongoing inflammation or stimulate repair and regeneration of cartilage tissues in OA.作者: BRAVE 時間: 2025-3-22 14:33 作者: BRAVE 時間: 2025-3-22 20:43 作者: Rejuvenate 時間: 2025-3-22 23:21 作者: Leisureliness 時間: 2025-3-23 05:19 作者: CLAN 時間: 2025-3-23 06:08 作者: 隱士 時間: 2025-3-23 10:43 作者: 哺乳動物 時間: 2025-3-23 17:54 作者: 終點 時間: 2025-3-23 18:56
Book 2010 to review the state of the art advances on topics ranging from disease entities to vectors and engineered cells. The different approaches described in each chapter take into consideration the biomedical knowledge of these diseases and address the complexities of delivering long-term genetic interve作者: modish 時間: 2025-3-23 22:10 作者: 教唆 時間: 2025-3-24 05:30
Euclidean and Hyperbolic Geometry,chronic toxicity. However, clinical translation is complicated by the dose-dependent acute toxic response following systemic vector injection. With a better understanding of vector-mediated toxicity and improved delivery methods, |HDAds may emerge as an important vector for gene therapy of human diseases.作者: Filibuster 時間: 2025-3-24 08:38
https://doi.org/10.1007/b138427lications. Issues concerning vectors, promoters and the therapeutic genes are discussed and ideal features for safe, non toxic, efficient and regulated gene expression proposed. Finally, the results from preclinical studies and six clinical trials performed in RA patients are described.作者: observatory 時間: 2025-3-24 13:25
https://doi.org/10.1057/9780230523210l development stages, some nucleic acid-based approaches for treating IBD have successfully progressed to early stages of clinical trials. In this chapter, we will focus on discussing these nucleic acid-based therapies as well as other potential new therapeutics for the treatment of IBD.作者: Commodious 時間: 2025-3-24 17:57 作者: 震驚 時間: 2025-3-24 22:52
The Structure of Space and Time,be effective in the disease. Animal studies have shown that treatment with immunomodulatory molecules like interleukin 10 or vasoactive intestinal peptide can influence salivary function positively while changing the local inflammatory environment. Future research will have to show whether this approach is feasible in humans.作者: mastopexy 時間: 2025-3-25 02:56
Classical Dynamics and Its Quantum Analogueswe will briefly allude to some of the known immunological defects encountered in lupus and summarise recent advance in identifying new susceptibility genetic factors. We will also provide an overview of biological agents used for treatment of patient groups and new directions for gene therapy.作者: 去掉 時間: 2025-3-25 04:16
Gene therapy for arthritis,lications. Issues concerning vectors, promoters and the therapeutic genes are discussed and ideal features for safe, non toxic, efficient and regulated gene expression proposed. Finally, the results from preclinical studies and six clinical trials performed in RA patients are described.作者: CROAK 時間: 2025-3-25 08:10 作者: 鳴叫 時間: 2025-3-25 13:48 作者: GLOSS 時間: 2025-3-25 18:11
,Gene therapy: Sj?gren’s syndrome,be effective in the disease. Animal studies have shown that treatment with immunomodulatory molecules like interleukin 10 or vasoactive intestinal peptide can influence salivary function positively while changing the local inflammatory environment. Future research will have to show whether this approach is feasible in humans.作者: Hemiparesis 時間: 2025-3-25 21:52 作者: cringe 時間: 2025-3-26 00:42 作者: interrogate 時間: 2025-3-26 06:48 作者: 補角 時間: 2025-3-26 11:49
https://doi.org/10.1007/b138427els, either through local gene delivery to the joint space or through systemic gene delivery for immune intervention. This chapter reviews how certain clinical applications of gene therapy would be beneficial for RA patients and discusses the roadblocks that need to be solved for future clinical app作者: 手工藝品 時間: 2025-3-26 15:40 作者: 艦旗 時間: 2025-3-26 18:11 作者: Collected 時間: 2025-3-26 23:44
https://doi.org/10.1007/978-3-030-76035-9nductance regulator) at the membrane of epithelial cells. Current treatment modalities aim to delay the deterioration in lung function, Which is mostly responsible for the relatively short life expectancy of CF sufferers; however none have so far successfully dealt with the underlying molecular defe作者: tolerance 時間: 2025-3-27 04:00 作者: phlegm 時間: 2025-3-27 05:36
https://doi.org/10.1007/978-0-387-09740-4 are characterised by the presence of endomysial inflammation. Each entity has unique clinical, immunopathological and histological characteristics which are associated with different responses to therapies and prognosis. In DM and PM, first-line treatment options include oral corticosteroids, other作者: 內(nèi)向者 時間: 2025-3-27 11:35
Introduction: Different Views of Psychologyar cartilage. Although joint damage contributes to the onset of OA, the continued synthesis of inflammatory cytokines, such as interleukin-1, by synovial cells and chondrocytes is thought to drive the progression of disease. Numerous naturally occurring proteins have been identified with the potenti作者: 豐滿有漂亮 時間: 2025-3-27 14:18 作者: 最初 時間: 2025-3-27 20:12
Classical Dynamics and Its Quantum Analoguesent disease mechanisms. The complex nature of lupus immunopathology has provided a fertile field to investigate disease mechanisms and explore new approaches for therapy. However, it is also this complexity that is hampering efforts to identify therapies that benefit most patients. In this chapter, 作者: 事先無準備 時間: 2025-3-28 00:45 作者: HUMID 時間: 2025-3-28 02:53 作者: 舉止粗野的人 時間: 2025-3-28 06:55
Classical Geometries in Modern Contextsst. The simplicity of its structure make it a safe vehicle for gene delivery, but this same attribute also means that delivery methods must be employed for plasmids to enter cells and gain access to the cell nucleus. These hurdles are overcome by a variety of chemical and physical delivery methods m作者: corn732 時間: 2025-3-28 11:23
Euclidean and Hyperbolic Geometry,void of viral coding sequences and are able to mediate high efficiency transduction in vivo to direct high level transgene expression with negligible chronic toxicity. However, clinical translation is complicated by the dose-dependent acute toxic response following systemic vector injection. With a 作者: 沒收 時間: 2025-3-28 14:50 作者: paleolithic 時間: 2025-3-28 19:34 作者: Coronary-Spasm 時間: 2025-3-29 00:24 作者: 顛簸地移動 時間: 2025-3-29 06:31
Gene Therapy for Autoimmune and Inflammatory Diseases978-3-0346-0165-8Series ISSN 2296-6056 Series E-ISSN 2296-6064 作者: BILIO 時間: 2025-3-29 08:10 作者: 皮薩 時間: 2025-3-29 11:39 作者: 標準 時間: 2025-3-29 17:10 作者: ULCER 時間: 2025-3-29 22:32 作者: 帶子 時間: 2025-3-30 00:35
Gene therapy of multiple sclerosis,ially understood, and the whole process is multi-focal, chronic, and occurring beyond anatomical barriers, making the delivery of potentially therapeutic molecules difficult. Gene therapy, thus, constitutes a realistic alternative to ensure prolonged, and site-specific delivery of therapies. Recent 作者: 飛行員 時間: 2025-3-30 04:57
Gene therapy for myositis, are characterised by the presence of endomysial inflammation. Each entity has unique clinical, immunopathological and histological characteristics which are associated with different responses to therapies and prognosis. In DM and PM, first-line treatment options include oral corticosteroids, other作者: CHIDE 時間: 2025-3-30 09:56 作者: CAMEO 時間: 2025-3-30 12:46 作者: expeditious 時間: 2025-3-30 18:02
Disease mechanisms, genetic susceptibility and therapeutic approaches in lupus disease,ent disease mechanisms. The complex nature of lupus immunopathology has provided a fertile field to investigate disease mechanisms and explore new approaches for therapy. However, it is also this complexity that is hampering efforts to identify therapies that benefit most patients. In this chapter, 作者: MOAN 時間: 2025-3-30 22:20 作者: 山間窄路 時間: 2025-3-31 01:29
Development of AAV vectors for the therapy of autoimmune and inflammatory diseases,, and muscle disorders. In these cases, the AAV vector has demonstrated both safety and efficacy; therapeutic transgene expression was observed in humans for greater than 5 years without associated side effects. Within the past decade, great progress has been achieved in AAV vector optimization for
